Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders??? (Deficit) Equity

v3.23.1
Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 9 $ 3,242 $ (5,922) $ (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070      
Net loss (10,017) (10,017)
Net proceeds from initial public offering   $ 5 22,266   22,271
Net proceeds from initial public offering (in Shares)   5,000,000      
Conversion of convertible notes into common stock $ 1 3,684 3,685
Conversion of convertible notes into common stock (in Shares)   736,773      
Issuance of common stock for exercise of options 59 59
Issuance of common stock for exercise of options (in Shares)   307,317      
Issuance of common stock for anti-dilution clause 2,191 2,191
Issuance of common stock for anti-dilution clause (in Shares)   438,374      
Stock-based compensation expense 966 966
Balance at Dec. 31, 2021 $ 15 32,408 (15,939) 16,484
Balance (in Shares) at Dec. 31, 2021   14,996,534      
Net loss (18,058) (18,058)
Issuance of common stock for cash, net of issuance costs   11 11
Issuance of common stock for cash, net of issuance costs (in Shares)   108,032      
Issuance of common stock     21   21
Issuance of common stock (in Shares)   33,500      
Issuance of common stock for vested restricted stock units
Issuance of common stock for vested restricted stock units (in Shares)   26,738      
Net proceeds from initial public offering        
Issuance of common stock for exercise of options 29 29
Issuance of common stock for exercise of options (in Shares)   66,851      
Stock-based compensation expense 1,047 1,047
Balance at Dec. 31, 2022 $ 15 $ 33,516 $ (33,997) $ (466)
Balance (in Shares) at Dec. 31, 2022 15,231,655